What You Should Know:
- Cytovale, a medical diagnostics company revolutionizing early disease detection secures $100M in Series D funding round led by Sands Capital with participation from new investor Canada Pension Plan Investment Board (CPP Investments) and existing investors.
- The investment will fuel the expansion of Cytovale's innovative sepsis diagnostic, IntelliSep, to more hospital emergency departments (EDs) and health systems nationwide.
IntelliSep:
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
IQIVIA Launches GenAI Assistant for Life Sciences
What You Should Know:
- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today introduces IQVIA AI Assistant, a generative AI technology that enables a step-change enhancement in how life science customers receive timely and powerful insights.
- IQVIA AI Assistant is a user-friendly, conversational text interface that provides immediate and intuitive analytic
Read More
Leveraging Technology to Improve Pharmaceutical Oversight and Patient Safety
In a time when healthcare is always changing, the pharmaceutical sector is under more pressure to ensure patient safety while maintaining compliance with stringent regulatory standards. As the complexity of pharmaceutical delivery rises, technology has become ever more crucial in tracking and safeguarding pharmacological products.
One especially remarkable development in this area is PharmaWatch, a real-time tracking system that enhances pharmaceutical control and enables healthcare
Read More
clock.bio Raises $5.3M to Decode Human Rejuvenation, Develop Anti-Aging Therapies
What You Should Know:
- clock.bio, a healthspan biotechnology company based at the Milner Therapeutics Institute in Cambridge, has secured $5.3M in seed funding to advance its groundbreaking research on human rejuvenation.
- The seed funding round was led by LocalGlobe, with participation from BlueYard Capital, Onsight Ventures, and Dr. Jonathan Milner, the Founder of Abcam.
Decoding the Secrets of Cellular Rejuvenation
clock.bio has developed a proprietary aging model
Read More
Advancing Drug Discovery with Quantum Computing and Supercomputer Tech
McKinsey & Company estimates it takes up to 12 years to introduce a new drug to the market – a lengthy timeline comprised of many factors including technology limitations, regulatory requirements, and patient recruitment and retention. Scientific innovation and clinical trials are increasingly complex, generating more data than ever. Researchers are facing difficulties managing the volume and variety of data, turning to artificial intelligence, machine learning and advanced data architecture
Read More
Pharmacogenomic Testing in Mental Health: The Need for a Broader Approach
What if we advised people to wear seatbelts only on certain days or when driving on specific highways? Clearly, this would result in real and avoidable harm. Unfortunately, something similar has happened to millions of patients who underwent pharmacogenomics (PGx) testing to aid in selecting drugs and doses for treating depression or anxiety, tailored to their unique genetics, without considering the broader implications. In mental health treatment, patients often endure multiple therapies
Read More
Bioinformatics: Why Life Sciences Must Adopt Open Science
Today's biomedical research can be complex and time-consuming, as researchers grapple with the challenging task of managing and analyzing ever-growing volumes of complex scientific data. Leveraging advanced bioinformatics tools and techniques is crucial for transforming this data into meaningful insights. Standardization and collaboration within the bioinformatics space is the solution enabling researchers to meet the demands of today. Sharing such analyses and findings across the
Read More
Flatiron Health and Lifebit Partner to Enhance Cancer Care in Japan through Real-World Data
What You Should Know:
- Flatiron Health, and Lifebit Biotech Ltd (UK, London; hereafter “Lifebit”), are expanding their collaboration into Japan to transform cancer care, facilitating ground breaking research by allowing for safe and secure access to real-world data (RWD).
- Building on the success of their multi-year strategic partnership, Lifebit’s pioneering federated Trusted Research Environment (TRE) technology will enable safe and secure access to Flatiron Health’s high-quality
Read More
5 Ways Tech is Enhancing Patient Engagement in Clinical Trials
Patient engagement is critical on several levels. It helps inform updates to trial design and processes, it ensures critical data is collected to determine the safety and efficacy of an investigational product, and it supports patient retention for the duration of the trial. That’s why biopharma sponsors and research sites are leaning into technology to facilitate this engagement. It’s important for physicians and other healthcare professionals to be aware of this technology and how it can
Read More
Biden vs. Trump: What the US Election Means for Drug Pricing
The global landscape for medical technology, biotechnology, and life sciences is on the cusp of seismic change.
The confluence of geopolitical tensions, economic uncertainty, and evolving social values has created a complex web of challenges and opportunities for these sectors around the world.
The broad life science industry too is in the midst of a period of significant transition. While the shadow of the pandemic recedes, its effects linger in the form of a market correction
Read More
